Dr. Zheng Wang 王征
Chief Physician
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation therapy and multidisciplinary care for pancreatic cancer, liver cancer, gallbladder/bile duct cancer, recurrent rectal cancer, and bone and soft tissue tumors.
Dr. Wang is a Chief Physician and Associate Professor with a medical doctorate. Deputy Director of the Abdominal and Pelvic Tumor Department at Shanghai Proton and Heavy Ion Hospital. Graduated from Soochow University in 2003 and Fudan University in 2015. Completed international carbon ion radiotherapy training at the National Institute of Radiological Sciences in Japan in 2015.
Professional roles
- Member, Pancreatic Cancer Expert Committee, Chinese Society of Clinical Oncology (CSCO)
- Member, Pancreatology Branch, China Medical Promotion Association
- Member, Proton and Heavy Ion Radiotherapy Professional Committee, China Health Care Association
- Member, Radiation Therapy Professional Committee, Shanghai Anti-Cancer Association
Name order: in Chinese the family name comes first (Wang Zheng). Papers usually list the name as Zheng Wang or Wang Z.
Selected publications
33 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Hepatobiliary Surg Nutr, 2026 (first author): Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition). PubMed 42273581
- Nat Commun, 2026 (senior author): INSIG1/2 succination mediated by the moonlighting function of ADSL promotes lipogenesis and liver tumorigenesis. PubMed 41833955
- Int J Radiat Oncol Biol Phys, 2025 (senior author): Prospective Phase 2 Clinical Trial of Carbon Ion Radiation Therapy Combined With Chemotherapy for Locally Advanced Pancreatic Carcinoma. PubMed 40614787
- J Radiat Res, 2023 (senior author): Definitive carbon ion re-irradiation with pencil beam scanning in the treatment of unresectable locally recurrent rectal cancer. PubMed 37738440
- Pancreatology, 2020 (senior author): Proton and carbon ion radiation therapy for locally advanced pancreatic cancer: A phase I dose escalation study. PubMed 32033896
- Cancer Lett, 2015 (first author): Radiosensitization of metformin in pancreatic cancer cells via abrogating the G2 checkpoint and inhibiting DNA damage repair. PubMed 26304716
- Radiat Oncol, 2015 (first author): Intensity modulated radiotherapy for locally advanced and metastatic pancreatic cancer: a mono-institutional retrospective analysis. PubMed 25575617
- Diabetes Res Clin Pract, 2014 (first author): Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. PubMed 24837144
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion